We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Samples Quality Improved Using Low-Vacuum Tubes

By LabMedica International staff writers
Posted on 16 Jul 2019
Centrifugation is a time consuming step, which contributes to increase the turnaround time (TAT) in laboratories, likewise hemolyzed samples that needs a re-sampling could delay management of patients.

So, the absence of hemolysis is one of the most important quality indicators for biochemistry as many analytes are influenced at the up or at the down with sample hemolysis. More...
The hemolysis index is a measurement of the red color of serum. This color is normally due almost exclusively to the presence of hemoglobin, which comes from ruptured red blood cell membranes.

Medical biochemists and their colleagues at the Lapeyronie University Hospital (Montpellier, France) evaluated the impact of replacing BD vacutainer heparin lithium tube by low-vacuum BD Vacutainer Barricor tube in an emergency department (ED) on hemolysis rate and TAT. In the first phase blood tests for biochemistry were all performed using 4 mL plastic BD Vacutainer lithium heparin tubes and tubes were then centrifuged during 15 minutes  at 2,000g in an emergency dedicated Multifuge X3 FR Centrifuge.

After this first period, all 4 mL BD Vacutainer lithium heparin tubes were removed from the ED and replaced by 3.5 mL BD Vacutainer Barricor lithium heparin tubes during the one day of transition. Hemolysis Index (HI) was measured in the conventional unit (free hemoglobin mg/dL) on all tubes using the Cobas 8000 Roche test SSI-2 on a c701 module. Eight chemistry analytes were measured on the four different Cobas 8000 modules.

The scientists reported that a significantly reduced time duration between reception of sample and available results in informatics laboratory system was observed with the reduction time of centrifugation allowed by use of Barricor tube compared to regular heparin lithium tubes. A statistical significant decrease in hemolysis rate also occurred in the second period as samples with HI  less than 10 reached from 52.5% in the first period to 68.5% in the second.

The authors concluded that their study highlighted two advantages when using low-vacuum Barricor tubes which was a reduction of centrifugation time allowing improvement of laboratory TAT and a reduction of hemolyzed samples that improve sample and result quality. The study was published on June 12, 2019, in the journal Practical Laboratory Medicine.

Related Links:
Lapeyronie University Hospital


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Monarch Mag Cell-free DNA (cfDNA) Extraction Kit provides isolation of low-abundance cfDNA from a range of biofluids (Photo courtesy of New England Biolabs)

New Extraction Kit Enables Consistent, Scalable cfDNA Isolation from Multiple Biofluids

Circulating cell-free DNA (cfDNA) found in plasma, serum, urine, and cerebrospinal fluid is typically present at low concentrations and is often highly fragmented, making efficient recovery challenging... Read more

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Pathology

view channel
Image: The innovative classifier can guide treatment for PDAC and other immunotherapy-resistant cancers (Photo courtesy of Adobe Stock))

Single Sample Classifier Predicts Cancer-Associated Fibroblast Subtypes in Patient Samples

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, in part because of its dense tumor microenvironment that influences how tumors grow and respond to treatment.... Read more

Industry

view channel
Image: QuidelOrtho has entered into a strategic supply agreement with Lifotronic to expand its global immunoassay portfolio (Photo courtesy of QuidelOrtho)

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.